Torrent Pharmaceuticals informs about outcome of board meeting

24 Jan 2025 Evaluate
Torrent Pharmaceuticals has informed that the Board has at its meeting held today approved the following: Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and nine months ended on 31st December, 2024. The said financial results are enclosed as Annexure-A. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and nine months ended on 31st December, 2024. Both Standalone and Consolidated Financial Results will be available at Company’s website www.torrentpharma.com. A Press Release on Financial Results which is being submitted to the media is also enclosed as Annexure-B;  An interim dividend of ? 26 (520%) per equity share of ? 5 fully paid up. The dividend is expected to be paid / dispatched on or around 17th February, 2025. Further, Maurice Chagnaud will be completing his term as an Independent Director of the Company on 10th May, 2025. The Board meeting commenced at 02:00 pm and concluded at 04:05 pm.

The above information is a part of company’s filings submitted to BSE.

Torrent Pharma Share Price

2945.30 -41.40 (-1.39%)
28-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1593.90
Dr. Reddys Lab 1117.65
Cipla 1410.95
Lupin 1906.20
Zydus Lifesciences 876.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...